WSJ: Stryker eyes takeover of Boston Scientific to form $110B company

Stryker approached Boston Scientific with a takeover bid on Monday, June 11, according to the Wall Street Journal.

Such a deal would combine two of the largest medical device manufacturers into a single company worth an estimated $110 billion. According to the Wall Street Journal, it was unclear if Boston Scientific would be receptive to such a move.

As of 11:10 a.m. (EST), Boston Scientific shares rose 7 percent after the initial WSJ report, while Stryker is trading down 2.7 percent.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.” 

The FDA recently cleared the company's cable-free, credit card-sized heart monitor that produces 12-lead ECGs.

If 25% tariffs go into effect, it could have a big impact on the cost of medical imaging and radiotherapy systems, with many manufacturing facilities in Mexico.